Report cover image

Global Human CALP(Calprotectin) ELISA Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Publisher GlobalInfoResearch
Published Dec 25, 2025
Length 147 Pages
SKU # GFSH20684685

Description

According to our (Global Info Research) latest study, the global Human CALP(Calprotectin) ELISA Kit market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.

Calcinin is a calcium-containing protein derived from neutrophils and macrophages. Its expression is tissue or cell specific and can be used as a marker of acute inflammatory cell activation. Caltin is widely distributed in human cells, tissues and body fluids. It is the main protein of granulocytes, monocytes and keratinocytes. Neutrophil calprotectin is distributed in the lysozyme cell fluid in vitro, accounting for approximately 5% of the total cellular protein. It is a marker of neutrophil renewal and is elevated under many inflammatory conditions. It can be detected in plasma, urine, stool, cerebrospinal fluid, saliva, synovial fluid, and colon biopsies.

This report is a detailed and comprehensive analysis for global Human CALP(Calprotectin) ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Human CALP(Calprotectin) ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human CALP(Calprotectin) ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human CALP(Calprotectin) ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human CALP(Calprotectin) ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Human CALP(Calprotectin) ELISA Kit

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Human CALP(Calprotectin) ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Actim Oy, Svar Life Science, BÜHLMANN Laboratories, EagleBio, CerTest Biotec S.L., Euroimmun, Boditech Med, Biohit Oyj, ALPCO Diagnostics, DiaSource Diagnostics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Human CALP(Calprotectin) ELISA Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
25 Servings/Box
50 Servings/Box
100 Servings/Box
Others

Market segment by Application
Hospital
Clinic

Major players covered
Actim Oy
Svar Life Science
BÜHLMANN Laboratories
EagleBio
CerTest Biotec S.L.
Euroimmun
Boditech Med
Biohit Oyj
ALPCO Diagnostics
DiaSource Diagnostics
R-Biopharm
Abbexa
AccuBio Tech
Screen Italia
Hangzhou Biotest Biotech
Thermo Fisher Scientific
Epitope Diagnostics
Elabscience Biotechnology
Vitassay Healthcare
Beckman Coulter
DiaSorin
BioVendor
Bioantibody

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human CALP(Calprotectin) ELISA Kit product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Human CALP(Calprotectin) ELISA Kit, with price, sales quantity, revenue, and global market share of Human CALP(Calprotectin) ELISA Kit from 2020 to 2025.

Chapter 3, the Human CALP(Calprotectin) ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human CALP(Calprotectin) ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human CALP(Calprotectin) ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Human CALP(Calprotectin) ELISA Kit.

Chapter 14 and 15, to describe Human CALP(Calprotectin) ELISA Kit sales channel, distributors, customers, research findings and conclusion.

Table of Contents

147 Pages
1 Market Overview
2 Manufacturers Profiles
3 Competitive Environment: Human CALP(Calprotectin) ELISA Kit by Manufacturer
4 Consumption Analysis by Region
5 Market Segment by Type
6 Market Segment by Application
7 North America
8 Europe
9 Asia-Pacific
10 South America
11 Middle East & Africa
12 Market Dynamics
13 Raw Material and Industry Chain
14 Shipments by Distribution Channel
15 Research Findings and Conclusion
16 Appendix
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.